BioSpace News Archive

According to the report, the global plant-based vaccines market was valued at US$ 1.10 Bn in 2020.

According to the report, the global orthopedic navigation systems market was valued at US$ 299.2 Mn in 2020.

According to the report, the global laboratory temperature control units market was valued at US$ 542.7 Mn in 2020 and is projected to expand at a moderate CAGR from 2021 to 2031.

According to the report, the global home diagnostics market was valued over US$ 5.34 Bn in 2020.

Bavarian Nordic A/S announced the initiation of a Phase 2 clinical trial of its COVID-19 vaccine candidate, ABNCoV2.

Masimo announced the findings of a study published in the Turkish Journal of Emergency Medicine in which Drs. Seda Dağar and Hüseyin Uzunosmanoğlu at the Kecioren Training and Research Hospital in Ankara, Turkey investigated the role that noninvasive, continuous Masimo PVi® might play in monitoring volume status and volume changes in spontaneously breathing patients undergoing hemodialysis.

Everest Medicines, a biopharmaceutical company focused on developing and commercializing transformative pharmaceutical products that address critical unmet medical needs for patients in Greater China and other parts of Asia, announced that it will report 2021 unaudited first half interim results after the closing of Hong Kong equity markets on August 30, 2021.

Axsome Therapeutics, Inc. announced that the U.S. Food and Drug Administration informed the Company in a teleconference on August 20, 2021, that its review of the new drug application for AXS-05 for the treatment of major depressive disorder would not be completed by the Prescription Drug User Fee Act target action date of August 22, 2021.

Nevro Corp. announced that D. Keith Grossman, Nevro’s Chairman, CEO and President, will present at the Wells Fargo Virtual Healthcare Conference on Friday, September 10, 2021 at 8:00 am Eastern Time / 5:00 am Pacific Time.

Affimed N.V., a clinical stage immuno-oncology company committed to giving patients back their innate ability to fight cancer, announced that it will release second quarter 2021 results on Wednesday, September 8, 2021, and host a conference call at 8:30 a.m. EDT to discuss financial results and recent corporate developments.